InfuSystem
INFU
$7.61
Share price
-3.30%
Change (1 day)
-12.43%
Change (1 year)
Categories
InfuSystem (INFU) - P/B ratio
P/B ratio as of April 2024 : 3.25
According to InfuSystem's latest financial reports the company has a price-to-book ratio of 3.25.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
InfuSystem - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.34 | 16.14% |
| 2022-12-31 | 3.74 | -48.85% |
| 2021-12-31 | 7.30 | -21.93% |
| 2020-12-31 | 9.35 | 23.18% |
| 2019-12-31 | 7.59 | 130.48% |
| 2018-12-31 | 3.29 | 94.63% |
| 2017-12-31 | 1.69 | 48.43% |
| 2016-12-31 | 1.14 | -15.7% |
| 2015-12-31 | 1.35 | -10.57% |
| 2014-12-31 | 1.51 | 37.53% |
| 2013-12-31 | 1.10 | 34.58% |
| 2012-12-31 | 0.8173 | -4.02% |
| 2011-12-31 | 0.8516 | 37.89% |
| 2010-12-31 | 0.6176 | 22.07% |
| 2009-12-31 | 0.5059 | 0.27% |
| 2008-12-31 | 0.5046 | -50.31% |
| 2007-12-31 | 1.02 | -36.46% |
| 2006-12-31 | 1.60 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Premier PINC | 1.04 | -67.92% | 🇺🇸 USA |
 DexCom DXCM | 26.4 | 712.59% | 🇺🇸 USA |
 CorVel Corporation
CRVL | 17.5 | 439.56% | 🇺🇸 USA |
 Biolase
BIOL | 0.8365 | -74.27% | 🇺🇸 USA |